Random Learning
← The journal

June 22, 2026

3 things I learned

last30days v3.3.2 · synced 2026-06-22

What I learned:

Tim Ferriss put hard numbers on the collapse and the whole industry is reacting to it - The trigger event for this entire conversation is Ferriss's June 12 essay "Has AI Already Killed How-To Nonfiction?", which @flipso summarized as Ferriss arguing "AI and chatbots are sharply reducing demand for prescriptive nonfiction, using his own book sales as evidence." His own data: print sales down 57% from 2024 to 2025, down 45% across all formats in the back half of the year, and a pace approaching ~80% off 2022 - laid out in his June 12 essay and amplified across the trade press (Jane Friedman): "I don't believe any constellation of footnotes begins to explain a near-vertical drop in prescriptive nonfiction."

Authors' core fear is that how-to books are now just a worse interface than a chatbot - The most-shared framing on X, via @xovionai, is Ferriss calling his own books "lookup tables and decision trees - ChatGPT gives you both, free." A Japanese thread from @__su888 spread the same numbers, and @BigGGGNiNa put the gut-punch plainly: "In just three years, the sales of practical how-to books have been cut in half." The publishing-side reaction is anxious rather than dismissive - Jane Friedman ran it as "Bestselling nonfiction author believes AI has devastated his book sales," quoting the agent line that "2025 was the first big drop, 2026 looks more severe, and the only thing that's really changed in that timeframe is the acceleration of AI."

Working self-publishers are scared and posting about it in real time - The fear is not abstract on r/selfpublish, where the live thread "How are you self publishing with all the fear surrounding AI?" pulled 43 comments of authors trying to figure out whether the category is even worth entering anymore.

But the counter-narrative is loud: maybe it's not (only) the chatbots - The Hacker News discussion on Ferriss's piece pushed back hard, per HN: commenters blamed the explosion of free library reading via Libby, argued "how-to nonfiction was pretty much killed by the internet years ago," and zeroed in on the survivable niche - "an AI can't tell you 'this is how I f*ked up my marriage and here are the 3 lessons I learned.'" Personal-narrative and memoir-flavored advice is where authors think the moat still is.

The other half of the story is AI flooding the supply side, not just draining the demand side - The category isn't only losing readers to ChatGPT; it's being buried in machine-written slop. Per the Originality.AI study of 844 titles in Amazon's "Success" self-help subcategory, 77% were likely AI-written and 90% carried at least some AI-generated elements - so real authors face thinner demand AND a slush pile of synthetic competitors. Meanwhile r/books is wrestling with the human side too, via the 1,877-upvote thread "The authors who admit to using AI: 'I have absolutely no shame about it'" (1,156 comments).

Publishers are responding with hedges, not a plan - The consensus framing, per Northeastern's reporting on the Q1 numbers (adult nonfiction down 9%, self-help down 26.3% YoY), is that "few know what to do." The visible moves so far: HarperCollins partnering with AI firms like Toonstar for short-form video adaptations, editors using AI to summarize manuscripts, and a Gotham Ghostwriters survey finding 61% of 1,481 writers now use AI tools - with the market rewarding AI-assisted work and penalizing fully AI-generated work.

KEY PATTERNS from the research: 1. Ferriss's essay is the single anchor event - nearly every author/publisher take in the window cites his sales data - per Jane Friedman 2. The dominant author thesis: prescriptive "lookup table" nonfiction is now a worse free interface than a chatbot, so it's the canary - per @xovionai 3. The strongest pushback says blame is multi-causal (Libby, the internet, podcasts), not AI alone - per HN 4. Authors believe the survivable niche is lived personal narrative AI can't fake - per HN 5. Supply-side AI slop (77% of "Success" self-help likely AI) compounds the demand-side drop - per Originality.AI 6. Publishers are improvising (AI adaptations, AI manuscript summaries) with no clear strategy - per Northeastern

last30days v3.3.2 · synced 2026-06-22

What I learned:

The doctors-vs-investors split is the whole story - The sharpest framing in the last 30 days came from The Hindu: "investors love them but doctors hate them." Elective whole-body MRI "lacks evidence of mortality or quality-of-life benefit and may cause harm through overdiagnosis, unnecessary procedures, and psychological distress." On X, a viral thread captured the clinical pushback bluntly: "Doctors are dunking on the full-body scanner... it's not hard to generate 'abnormal' findings (benign lesions and tumors) → follow-up imaging → specialist visits → biopsies → potentially surgery," warning that at population scale, overdiagnosis "can lead to more deaths and complications than lives saved."

The incidental-findings numbers are why clinicians are nervous - This is the most-cited hard data across sources. Biograph and others note systematic reviews showing 20-40% of scans produce incidental findings of unclear significance; one review found "95% of participants had abnormal findings, about a third required further investigation, and fewer than 0.5% had findings suspicious for cancer." A 3,371-person study via Health Review Network found 30.3% got an incidental finding and 62.1% of resulting biopsies showed no malignancy. Michigan Medicine and the American College of Radiology both decline to recommend total-body MRI for average-risk, asymptomatic adults - unlike mammography, colonoscopy, and low-dose CT, it has no USPSTF backing.

The "false reassurance" risk got a real-world cautionary tale - The Washington Post reported a lawsuit alleging Prenuvo's full-body MRI missed signs of a catastrophic stroke. This is the flip side critics keep raising: scans miss things too (the X thread flagged "false negatives... early colon" cancers), so a clean scan can breed dangerous overconfidence.

People who actually tried it mostly liked the experience - and that's separate from whether it's medically useful - First-person testimony skews positive on vibe and reassurance. A TikTok reviewer via Full Body Health Scan said of Prenuvo: "Overall I'm so happy I finally have answers about my health. Totally worth it." UK reviewers of Neko, like the Cotswold Journal, called it "a great way to reassure yourself that you have good health, but also it's so important for identifying problems before they become problems." The recurring user verdict: the experience is futuristic and reassuring, but that's a different question from clinical value.

Neko's positioning is "affordable luxury," and the value complaints are loudest there - Vogue frames Neko (from Spotify's Daniel Ek) as the faster, cheaper, more scalable answer to Prenuvo and Ezra's $2,500+ MRIs - roughly £299/$400 for an hour-long AI check-up. But Trustpilot reviewers are split: praise for efficient, knowledgeable staff and free follow-ups, against complaints it's "a very weak offering for the price" delivering "simple details already available through a GP."

Celebrity marketing is fueling the hype the doctors are pushing back on - @ParisHilton plugged Prenuvo to her followers ("Love @prenuvo for its whole body MRI, blood biomarker testing and personalized results") with a free-scan giveaway, and Prenuvo is bundled into perks like Chase Sapphire Reserve and Hims memberships. That influencer-and-perks engine is exactly the "uptake has moved faster than the evidence base" dynamic clinicians flag.

KEY PATTERNS from the research: 1. The expert consensus is "not for healthy asymptomatic people" - no major cancer or radiology society endorses whole-body MRI screening absent risk factors, per Michigan Medicine 2. Incidental findings are the core harm: high abnormal-finding rates, low confirmed-cancer yield, cascading biopsies that are mostly benign, per Biograph 3. People who paid mostly liked the experience and the reassurance, even when the medical payoff is unproven, per first-person TikTok and local-press reviews 4. "Worth it" is conditional - skeptics and even proponents converge on: more defensible for those with strong family history or genetic risk than for the average healthy adult, per The Hindu 5. False negatives matter too - a clean scan can create dangerous false reassurance, dramatized by the Prenuvo missed-stroke lawsuit, per The Washington Post

Provenance — 2026-06-22

Three saved items from the personal library seeded today's run. Picked for genuine personal pull and domain spread — the pool leans heavily toward AI-coding tooling, and the recent week already covered Japanese urban economics, so today deliberately ranged across the publishing economy, web preservation, and consumer health-tech, with no second helping of Japan/urbanism.

Source entries (3)

  1. A piece on AI eroding how-to / self-help book sales — Rationale: a strong personal reaction that this whole category may be dying; worth checking against what authors and publishers actually say.
  2. An artifact-style relic of the early personal web — Rationale: affection for old web pages as preserved artifacts; pulled the thread toward what survives and what rots.
  3. A consumer AI company's pivot into a health scanner — Rationale: surprise at the pivot; curiosity about whether full-body scanning is real medicine or expensive vibe.

Fan-out — 12 adjacent candidates

From entry 1 (AI vs. nonfiction publishing): - The collapsing economics of how-to / self-help publishing as readers ask AI ✅ chosen - Which kinds of books stay AI-proof: memoir, narrative, lived experience - Authors abandoning books for cohorts, communities, and courses - A book as a credential / proof of authority vs. the information inside it

From entry 2 (early web as artifact): - Link rot and the digital dark age: how much of the web has vanished ✅ chosen - Web archiving tools and practices people actually run in 2026 - The small-web / indie-web revival: personal sites and webrings - Reconstructing dead platforms (Geocities, Flash) for preservation

From entry 3 (AI health scanner pivot): - Diffusion / generative image models repurposed for medical imaging - Consumer AI companies pivoting into regulated healthcare verticals - Full-body AI health scanners and longevity screening: hype vs. evidence ✅ chosen - FDA clearance of AI diagnostic tools: what is actually getting approved

All 12 cleared the near-dup guard against the published index. The 3 chosen scored well below the dedup threshold against prior topics (top matches ≈0.1) — genuinely new ground, no connections above the related-topic threshold.

Final 3 topics

  1. The collapsing economics of how-to / self-help book publishing as readers ask AI → ai-killing-nonfiction.md
  2. Link rot and the digital dark age: how much of the web has already vanished → link-rot-digital-dark-age.md
  3. Full-body AI health scanners and longevity screening: hype versus evidence → full-body-health-scanners.md

Each researched via last30days v3.3.2 (agent mode). Raw evidence was written to a temp directory outside the repo and is not committed.